![Joseph Reilly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Reilly
Comptroller/Controller/Auditor chez
ARDELYX, INC.
Fortune : 498 821 $ au 30/09/2026
Profil
Joseph Reilly is Chief Accounting Officer at Ardelyx, Inc. since 2024.
Mr. Reilly was Vice President-Global Markets Controller at Bristol Myers Squibb Co. in 2024.
Mr. Reilly completed undergraduate studies at Syracuse University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARDELYX, INC. 0,06% | 21/08/2026 | 145 854 ( 0,06% ) | 498 821 $ | 30/09/2026 |
Postes actifs de Joseph Reilly
| Sociétés | Poste | Début |
|---|---|---|
| ARDELYX, INC. | Comptroller/Controller/Auditor | 15/11/2024 |
Anciens postes connus de Joseph Reilly
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/09/2024 |
Formation de Joseph Reilly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
